These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 12673802)
1. Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene. van der Sluijs BM; van Engelen BG; Hoefsloot LH Hum Mutat; 2003 May; 21(5):553. PubMed ID: 12673802 [TBL] [Abstract][Full Text] [Related]
2. Study of a Taiwanese family with oculopharyngeal muscular dystrophy. Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel mutation in a Korean patient with oculopharyngeal muscular dystrophy. Bae JS; Ki CS; Kim JW; Kim BJ J Clin Neurosci; 2007 Jan; 14(1):89-92. PubMed ID: 17138075 [TBL] [Abstract][Full Text] [Related]
4. [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene]. Pou Serradell A; Lloreta Trull J; Corominas Torres JM; Hammouda EH; Urtizberea JA; Richard P; Brais B Neurologia; 2004 Jun; 19(5):239-47. PubMed ID: 15150706 [TBL] [Abstract][Full Text] [Related]
5. (GCG)11 founder mutation in the PABPN1 gene of OPMD Uruguayan families. Rodríguez M; Camejo C; Bertoni B; Braida C; Rodríguez MM; Brais B; Medici M; Roche L Neuromuscul Disord; 2005 Feb; 15(2):185-90. PubMed ID: 15694141 [TBL] [Abstract][Full Text] [Related]
6. Two cases of oculopharyngeal muscular dystrophy (OPMD) with the rare PABPN1 c.35G>C; p.Gly12Ala point mutation. Robinson DO; Hilton-Jones D; Mansfield D; Hildebrand GD; Marks S; Mechan D; Ramsay J Neuromuscul Disord; 2011 Nov; 21(11):809-11. PubMed ID: 21742497 [TBL] [Abstract][Full Text] [Related]
7. Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder. Davies JE; Berger Z; Rubinsztein DC Int J Biochem Cell Biol; 2006; 38(9):1457-62. PubMed ID: 16530457 [TBL] [Abstract][Full Text] [Related]
8. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects. Rivera D; Mejia-Lopez H; Pompa-Mera EN; Villanueva-Mendoza C; Nava-Castañeda A; Garnica-Hayashi L; Cuevas-Covarrubias S; Zenteno JC Br J Ophthalmol; 2008 Jul; 92(7):998-1002. PubMed ID: 18577654 [TBL] [Abstract][Full Text] [Related]
9. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy. Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821 [TBL] [Abstract][Full Text] [Related]
10. [Preferential distal muscle involvement in case of oculopharyngeal muscular dystrophy with (GCG) 13 expansion]. Nakashima D; Nakajima H; Ishida S; Sugino M; Kimura F; Hanafusa T Rinsho Shinkeigaku; 2003 Sep; 43(9):560-3. PubMed ID: 14727564 [TBL] [Abstract][Full Text] [Related]
11. Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy. Davies JE; Rose C; Sarkar S; Rubinsztein DC Sci Transl Med; 2010 Jun; 2(34):34ra40. PubMed ID: 20519718 [TBL] [Abstract][Full Text] [Related]
12. Oculopharyngeal muscular dystrophy (OPMD): analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism. Robinson DO; Hammans SR; Read SP; Sillibourne J Hum Genet; 2005 Mar; 116(4):267-71. PubMed ID: 15645184 [TBL] [Abstract][Full Text] [Related]
13. Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation. Robinson DO; Wills AJ; Hammans SR; Read SP; Sillibourne J J Med Genet; 2006 May; 43(5):e23. PubMed ID: 16648376 [TBL] [Abstract][Full Text] [Related]
14. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC Nat Med; 2005 Jun; 11(6):672-7. PubMed ID: 15864313 [TBL] [Abstract][Full Text] [Related]
15. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy. Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585 [TBL] [Abstract][Full Text] [Related]
16. Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman. Goh KJ; Wong KT; Nishino I; Minami N; Nonaka I Neuromuscul Disord; 2005 Mar; 15(3):262-4. PubMed ID: 15725589 [TBL] [Abstract][Full Text] [Related]